title: The KRAS Variant as a Predictive Biomarker of Cetuximab Response in Head and Neck Cancer.
authors.affiliation: Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
authors.forename: Jeffrey P
authors.initials: JP
authors.lastname: Bruce
authors.affiliation: Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada2Division of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Wei
authors.initials: W
authors.lastname: Xu
authors.affiliation: Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada4Departments of Radiation Oncology and Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Fei-Fei
authors.initials: FF
authors.lastname: Liu
mesh_terms: D015415:Biomarkers; D000068818:Cetuximab; D004847:Epithelial Cells; D006258:Head and Neck Neoplasms; D006801:Humans; D016283:Proto-Oncogene Proteins p21(ras)
chemical_list: D015415:Biomarkers; C117307:KRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras); D000068818:Cetuximab